• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Monitored anesthesia care during mechanical thrombectomy for stroke: need for data-driven and individualized decisions
Conclusions Our study showed that the overall rate of conversion from MAC to GA during MT was low (1.6%) and, while higher in posterior circulation strokes, it was not predicted by either hemispheric dominance or stroke severity. Caution should be given before changing clinical practice during moments of crisis.
Source: Journal of NeuroInterventional Surgery - November 18, 2021 Category: Neurosurgery Authors: Nogueira, R. G., Mohammaden, M. H., Moran, T. P., Whalin, M. K., Gershon, R. Y., Al-Bayati, A. R. R., Ratcliff, J., Pisani, L., Liberato, B., Bhatt, N., Frankel, M. R., Haussen, D. C. Tags: Ischemic stroke, COVID-19 Source Type: research

Impact of COVID-19 Pandemic on a Regional Stroke Thrombectomy Service in the United Kingdom
Conclusion: The COVID-19 pandemic has had a negative impact on the stroke admission numbers but not stroke thrombectomy rate, successful recanalization rate, or early neurological outcome. Internal delays actually improved during the COVID-19 pandemic. Further studies should examine the effects of the COVID-19 pandemic on longer term outcome.Cerebrovasc Dis
Source: Cerebrovascular Diseases - December 11, 2020 Category: Neurology Source Type: research

IJERPH, Vol. 18, Pages 9464: The Impact of the Pandemic on Acute Ischaemic Stroke Endovascular Treatment from a Multidisciplinary Perspective: A Nonsystematic Review
Conclusions: Adequate management of AIS patients requiring mechanical thrombectomy during the pandemic is of paramount importance to maximise the benefit of the endovascular procedure. MDT work and familiarity with NORA principles decrease the negative impact of the disease on the clinical outcomes for AIS patients.
Source: International Journal of Environmental Research and Public Health - September 8, 2021 Category: Environmental Health Authors: Grigonyte Kraujelyte Januskeviciute Semys Kriukelyte Kontrimaviciute Valeviciene Jatuzis Tags: Review Source Type: research

Management of Endovascular Treatment for Acute Ischemic Stroke During the COVID-19 Pandemic at a Single Institution in Beijing, China: A Brief Report
Background: The coronavirus disease (COVID-19) pandemic is currently a major challenge for health care systems around the world. For a time-sensitive emergency such as acute ischemic stroke (AIS), streamlined workflow times are essential to ensure good clinical outcomes. Methods: The aim of this single-center, retrospective, observational study was to describe changes in stroke workflow patterns and clinical care during the COVID-19 pandemic. Data from AIS patients undergoing emergent endovascular treatment (EVT) between 23 January and 8 April 2020 were retrospectively collected and compared with data from patie...
Source: Journal of Neurosurgical Anesthesiology - June 18, 2021 Category: Anesthesiology Tags: Short Reports Source Type: research

How John Fetterman Came Out of the Darkness
When he looks back on the past year—a year in which he nearly died, became a U.S. Senator, and nearly died again—it is the debate that John Fetterman identifies as the ­breaking point. “The debate lit the mitch,” he says, then shakes his head in frustration and tries again. The right word is there in his brain, but he struggles to get it out. “Excuse me, that should be lit the mitch—” He stops and tries again. “Lit the match,” he says finally. Oct. 25, 2022: the date is lodged in his mind. “I knew I had to do it,” he tells me. “I knew that the vote...
Source: TIME: Health - July 20, 2023 Category: Consumer Health News Authors: Molly Ball Tags: Uncategorized Congress Cover Story Exclusive feature uspoliticspolicy Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in p...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Bibliometric analysis of the worldwide scientific production on COVID-19 infection and cerebrovascular disease
CONCLUSION: It was observed that the United States was the country with the highest scientific production on COVID-19 and cerebrovascular disease in the year 2020 in the different health areas; however, more research is still needed worldwide for a better analysis of the bibliometric indicators on the subject.PMID:37706386 | DOI:10.4103/aca.aca_70_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Camila Palomino-Leyva Jhonny Rivera-Recuenco Alicia Fernandez-Giusti John Barja-Ore Yesenia Retamozo-Siancas Frank Mayta-Tovalino Source Type: research

Featured Review: Oxygen therapy in adult intensive care patients with acute respiratory distress syndrome
Approaches to guiding oxygen therapy in adult intensive care patients with acute respiratory distress syndromeAcute respiratory distress syndrome (ARDS) is a very severe breathing problem with a high mortality rate (chance of dying). It has many potential causes, including viral infections such as COVID-19, and there are no specific treatments for it except for giving patients oxygen via a ventilator (artificial breathing machine) on an intensive care unit, often for long periods of time. However, large amounts of oxygen (either a high concentration of oxygen or oxygen administered for a long period of time) are known to i...
Source: Cochrane News and Events - August 31, 2020 Category: Information Technology Authors: Katie Abbotts Source Type: news

Neurological Injury in COVID-19 Patients Who Receive VV-ECMO Therapy: A Cohort Study
Both thrombotic and bleeding events have been implicated in the progression of Coronavirus disease 2019 (COVID-19).1,2 Such dysregulation of coagulation has been associated with poor prognosis.3,4 Neurologic sequelae, such as ischemic stroke and intracranial hemorrhage (ICH), have been reported in COVID-19 patients at rates of 0.9%-2.3% and 0.9%, respectively.5,6,7,8 Limited data exists on neurological events in COVID-19 patients in the intensive care unit (ICU) who require extracorporeal membrane oxygenation (ECMO) due to severe acute respiratory distress syndrome (ARDS).
Source: Journal of Cardiothoracic and Vascular Anesthesia - May 13, 2021 Category: Anesthesiology Authors: Nivedha V. Kannapadi, Meghana Jami, Lavienraj Premraj, Eric W. Etchill, Katherine Giuliano, Errol L. Bush, Bo Soo Kim, Stella Seal, Glenn Whitman, Sung-Min Cho Tags: Letter to the Editor Source Type: research

Pages: 1  2